Skip to content

Free cash flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
GLW
CorningGLW
$30M+153%
Danaher logo
DanaherDHR
$1.09B+2.9%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
$13.55M+13.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$11.0B+6.2%
Operating income$1.9B+8.6%
Net income$1.7B+9.6%
EPS (diluted)$4.43+11.3%

Balance sheet

See full
Cash & equivalents$3.3B-21.4%
Total debt$43.2B+16.6%
Total equity$51.9B+5.2%
Total assets$113.28B+14.4%

Cash flow

See full
Operating cash flow$1.2B+64.9%
CapEx$376.0M+3.9%

Valuation

See full
Market cap$187.95B+25.1%
Enterprise value$227.83B+24.5%
P/E27.5×+4.4×
P/S4.3×-0.8×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%-0.2pp
Debt / equity0.8×+0.1×
Current ratio1.5×-0.2×

Where this comes from

Calculated from Thermo Fisher Scientific’s reported figures.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's free cash flow?
Thermo Fisher Scientific (TMO) reported free cash flow of $816M in Q1 2026.
How has Thermo Fisher Scientific's free cash flow changed year-over-year?
Thermo Fisher Scientific's free cash flow increased by 126.0% year-over-year, from $361M to $816M.
What is the long-term trend for Thermo Fisher Scientific's free cash flow?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's free cash flow has grown at a -1.9% compound annual growth rate (CAGR), from $6.79B to $6.29B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.